dobutamine has been researched along with carbostyril in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanoi, H; Fujita, M; Ishizaka, S; Kameyama, T; Nozawa, T; Sasayama, S | 1 |
| Ishikawa, M; Itoh, S; Koga, K; Mori, T; Tominaga, M; Yabuuchi, Y | 1 |
| Ishihara, H; Kanda, H; Kato, R; Nagata, K; Sobue, T; Yokota, M | 1 |
| Ishihara, H; Iwase, M; Machii, T; Nagata, K; Sobue, T; Yokota, M | 1 |
| Abraham, WT; Bristow, MR; Ferguson, DA; Lindenfeld, J; Lowes, BD; Scheffel, CA; White, M; Wolfel, EE | 1 |
| Hernández, J; Juan-Fita, MJ; Vargas, ML | 1 |
2 trial(s) available for dobutamine and carbostyril
| Article | Year |
|---|---|
A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
Topics: Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Middle Aged; Oxygen Consumption; Prospective Studies; Quinolones; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 1996 |
Effect of dobutamine and OPC-18790 on diastolic chamber stiffness in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Diastole; Dobutamine; Female; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left | 1997 |
4 other study(ies) available for dobutamine and carbostyril
| Article | Year |
|---|---|
[End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness].
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Dobutamine; Drug Evaluation; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Quinolones; Systole; Vena Cava, Inferior; Ventricular Function, Left | 1991 |
Differential effects of OPC-18790, amrinone and dobutamine on cardiac function and energy metabolism in the guinea-pig isolated ischaemic heart.
Topics: Adenosine Triphosphate; Amrinone; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Circulation; Dobutamine; Energy Metabolism; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardial Ischemia; Phosphocreatine; Quinolones; Ventricular Function, Left | 1995 |
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left | 1994 |
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines | 2005 |